Efficacy and Safety Study of Nasacort in Chronic Non Allergic and Non Infectious Rhinitis in Adults
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To demonstrate the superiority of the clinical efficacy of 12 weeks' treatment with Nasacort
versus placebo in adult patients presenting with Chronic Non Allergic and Non Infectious
Rhinitis